Corient Private Wealth’s Core Laboratories CLB Stock Holding History

Corient Private Wealth’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$141K	Sell	12,087 -1,647	-12%	-$23.5K	﹤0.01%	2877
2026 Q1	$231K	Buy	13,734 +95	+0.7%	+$1.7K	﹤0.01%	2475
2025 Q4	$219K	Buy	+13,639	New	+$203K	﹤0.01%	2374
2025 Q1	–	Sell	-10,953	Closed	-$190K	–	2317
2024 Q4	$190K	Buy	10,953 +32	+0.3%	+$617	﹤0.01%	2133
2024 Q3	$202K	Buy	10,921 +127	+1%	+$2.55K	﹤0.01%	2221
2024 Q2	$219K	Sell	10,794 -272	-2%	-$4.81K	﹤0.01%	2080
2024 Q1	$189K	Buy	+11,066	New	+$174K	﹤0.01%	2115

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Corient Private Wealth's CLB Position: Q2 2026 in Review

Corient Private Wealth reduced its Core Laboratories (CLB) stake by 12% in Q2 2026, selling an estimated $23.5K and leaving 12,087 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2877.

Corient Private Wealth first reported a position in CLB in Q1 2024 and has held it in 7 quarters since. The position peaked at $231K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Corient Private Wealth held 12,087 shares of Core Laboratories worth $141K as of Q2 2026.
Corient Private Wealth sold 1,647 Core Laboratories shares in Q2 2026, an estimated $23.5K.
Core Laboratories made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2877 holding.
Corient Private Wealth first reported a position in Core Laboratories in Q1 2024 and has held it in 7 quarters since.
Corient Private Wealth's Core Laboratories position peaked at $231K in Q1 2026.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.